There are many different bloodborne pathogens including Hepatitis C, malaria, or syphilis, but Hepatitis B (HBV) and the Human Immunodeficiency Virus (HIV) are the two diseases specifically addressed ...

Researchers at the World Health Organization have identified 17 pathogens most in need of new or improved vaccines, including threats like HIV, malaria, and influenza.

The World Health Organisation has spotlighted 17 pathogens critical for vaccine development. Urgent vaccines are needed against diseases like malaria, HIV, tuberculosis and more.

The World Health Organization on Tuesday listed 17 pathogens that cause widespread disease and death, including HIV, malaria and tuberculosis, for which it said new vaccines were "urgently needed." ...

Scientists at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institution under the ...

They found that these unique immune responses are essential for rhesus CMV-based vaccines to be effective against SIV, the pathogen most used to model HIV/AIDS in nonhuman primates. "To develop an ...

WHO listed Group A streptococcus, Hepatitis C virus, HIV-1 and Klebsiella pneumoniae as pathogens where vaccine research is needed. On pathogens where vaccines need to be further developed ...

HIV is a virus that attacks the immune system, making it harder to fight infections like BV. Infections like BV disrupt the natural vaginal environment, reducing the levels of protective bacteria, ...

The WHO study is the first global effort to systematically prioritize endemic pathogens based on criteria ... and development (R&D), including for HIV, malaria, and tuberculosis – three diseases ...

In children with HIV, whose immune systems are poor, any intervention that could inadvertently increase infection risk is ...

The World Health Organisation (WHO) had on Tuesday named HIV, malaria, Tuberculosis, and 14 other pathogens as top priorities ...

According to the study, three diseases- HIV, malaria, and tuberculosis - claim nearly 2.5 million lives annually, reinforcing the need for continued vaccine research and development (R&D).